List of insiders holdings for Cellectar Biosciences Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner |
2015-02-03 17:04:49 | 0 2,208,368 |
2,208,368 | Form 4 |
| 2 | AWM Investment Company Inc. 10% Owner |
2016-01-11 14:40:48 | 1,066,000 0 |
1,066,000 | Form 13G |
| 3 | CARUSO JAMES V President and CEO |
2025-02-18 16:01:16 | 900,000 0 |
900,000 | Form 4 |
| 4 | WISCONSIN ALUMNI RESEARCH FOUNDATION 10% Owner |
2016-12-02 13:19:57 | 602,817 0 |
602,817 | Form 13D |
| 5 | Elefant Dov Chief Financial Officer |
2022-01-27 16:06:06 | 422,000 0 |
422,000 | Form 4 |
| 6 | Friend John E. II Chief Medical Officer |
2021-03-05 17:46:09 | 330,000 0 |
330,000 | Form 4 |
| 7 | Pedder Simon President and CEO |
2014-08-22 16:38:50 | 290,878 0 |
290,878 | Form 4 |
| 8 | Kolean Chad J Chief Financial Officer |
2025-02-18 16:04:18 | 290,000 0 |
290,000 | Form 4 |
| 9 | Hertzberg Richard significant owner |
2016-11-01 20:45:15 | 280,000 0 |
280,000 | Form 4 |
| 10 | Shustov Andrei Senior Vice President, Medical |
2024-06-18 17:03:28 | 260,000 0 |
260,000 | Form 4 |
| 11 | Lea Darrell Shane Chief Commercial Officer |
2024-06-18 17:02:59 | 260,000 0 |
260,000 | Form 4 |
| 12 | BERNS PAUL L Director |
2016-04-21 18:01:54 | 234,742 0 |
234,742 | Form 4 |
| 13 | Cormorant Asset Management LLC Chen Bihua Cormorant Global Healthcare GP LLC Cormorant Global Healthcare Master Fund LP 10% Owner |
2017-02-14 16:17:33 | 106,648 0 |
106,648 | Form 13G |
| 14 | Swirsky Douglas J Director |
2025-02-18 16:07:24 | 90,000 0 |
90,000 | Form 4 |
| 15 | Longcor Jarrod Chief Operating Officer |
2025-03-12 21:44:18 | 83,141 0 |
83,141 | Form 4 |
| 16 | Grachev Igor D Chief Medical Officer |
2020-01-08 16:02:19 | 80,000 0 |
80,000 | Form 4 |
| 17 | Chanan-Khan Asher Director |
2025-02-18 16:02:37 | 60,000 0 |
60,000 | Form 4 |
| 18 | DRISCOLL FREDERICK W Director |
2025-02-18 16:03:34 | 60,000 0 |
60,000 | Form 4 |
| 19 | Loren Stefan Director |
2025-02-18 16:05:52 | 60,000 0 |
60,000 | Form 4 |
| 20 | NEIS JOHN Director |
2025-02-18 16:06:31 | 60,000 0 |
60,000 | Form 4 |
| 21 | HILL STEPHEN A Director |
2020-06-25 16:22:59 | 50,000 0 |
50,000 | Form 4 |
| 22 | Szakacs Cameron VP of Clinical Development |
2014-12-18 16:06:07 | 50,000 0 |
50,000 | Form 4 |
| 23 | Weichert Jamey P Chief Scientific Officer |
2016-05-23 19:42:18 | 42,895 0 |
42,895 | Form 4 |
| 24 | POSNER BRIAN M Chief Financial Officer |
2019-01-18 16:17:46 | 30,000 0 |
30,000 | Form 4 |
| 25 | McNeil Kathryn M See Remarks |
2014-08-18 10:57:43 | 20,000 0 |
20,000 | Form 3 |
| 26 | Genn John Patrick VP of Business Development |
2015-03-04 19:06:15 | 10,000 0 |
10,000 | Form 4 |
| 27 | Bernhardt Charles Thomas III Interim CFO |
2019-03-11 16:02:22 | 0 0 |
0 | Form 3 |
| 28 | Hamill John P. Interim CFO |
2017-09-08 11:58:26 | 0 0 |
0 | Form 3 |